Welcome to our dedicated page for Banco Bilbao SEC filings (Ticker: BBVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) (NYSE: BBVA) provides access to the bank’s regulatory disclosures as a foreign private issuer. BBVA files its annual report on Form 20-F and uses Form 6-K to furnish current reports and other relevant information under the Securities Exchange Act of 1934.
Recent Form 6-K filings describe a range of capital management and funding actions. These include announcements of buyback programs for BBVA’s own shares, with details on maximum aggregate cash amounts, execution periods, trading venues and the role of an external manager executing purchases independently. Filings also cover the completion of a buyback program, specifying the total number of own shares acquired and the percentage of share capital they represented, and explaining that the purpose of the program is to reduce BBVA’s share capital through the redemption of those shares.
Other filings report the partial execution of a share capital reduction resolution adopted by the Ordinary General Shareholders’ Meeting, implemented via the cancellation of tens of millions of treasury shares. These documents outline the resulting share capital, the accounting treatment through reserves for redeemed capital, and the intention to request delisting and cancellation of the redeemed shares in the relevant securities settlement systems.
BBVA’s Form 6-K submissions also include information on hybrid capital instruments. One filing announces the bank’s irrevocable decision, subject to prior regulatory consent, to redeem in whole an issuance of green preferred securities contingently convertible into ordinary shares of BBVA on a specified redemption date, and describes the redemption price as equal to the liquidation preference plus accrued and unpaid distributions, subject to the terms and conditions of the issuance.
Through Stock Titan, users can review these BBVA filings as they are furnished to EDGAR and use AI-powered summaries to interpret the implications of share buybacks, capital reductions, hybrid capital redemptions and other regulatory disclosures for the bank’s capital structure and governance.
Banco Bilbao Vizcaya Argentaria (BBVA) confirms it will maintain its voluntary tender offer for all shares of Banco de Sabadell despite recent actions by Sabadell. On August 6, 2025, Sabadell shareholders approved the sale of all shares and certain securities of its UK subsidiary TSB Banking Group plc to Banco Santander, subject to conditions precedent.
Sabadell’s meeting also approved an extraordinary cash dividend of €0.50 per share, to be paid from freely distributable voluntary reserves once the TSB sale is completed. Under Article 33.1(d) of Royal Decree 1066/2007, these resolutions entitled BBVA to withdraw its offer, with prior CNMV approval. After reviewing the resolutions and available information, BBVA chose not to withdraw, so the tender offer remains in effect under applicable regulations.
BANCO BILBAO VIZCAYA ARGENTARIA, S.A. filed a Form 13F reporting institutional holdings. The report lists 691 information-table entries with a total market value of $11,030,917,106 and names 11 other included managers. The filing is signed by Maria Angeles Pelaez Moron, Chief Accounting Officer.
BBVA filed a Form 6-K disclosing results of the 2025 EU-wide EBA stress test covering 2025-2027. The exercise, used for the 2025 Supervisory Review and Evaluation Process, applies a static 31-Dec-24 balance sheet and has no pass/fail threshold.
Baseline scenario: the bank’s fully-loaded CET1 ratio would rise 3.55 pp to 16.43 % by 31-Dec-27.
Adverse scenario: CET1 would fall 2.18 pp to a trough of 10.70 % in 2025, then recover to 11.02 % by 2027, remaining in double-digit territory throughout. No management actions or post-2024 business changes are reflected.
Results indicate BBVA can absorb a severe macro-financial shock while maintaining capital well above typical regulatory minima, supporting dividend capacity and funding flexibility. Investors should watch the forthcoming SREP decision and any updates to capital distribution policy.
BBVA delivered another strong set of results in 2Q25 despite a softer rate backdrop. Net attributable profit reached €2.75 bn, up 18 % YoY at constant FX, driving 6M25 profit to €5.45 bn (+31 %). ROTE climbed to 20.4 % and EPS was €0.46. Core income continued to expand: net interest income rose 11 % YoY (cc) to €6.21 bn and fees grew 18 % to €1.95 bn, more than offsetting a 49 % drop in trading income. Operating jaws remained positive and the cost-to-income ratio improved to 37.6 % (6M).
Asset quality was contained: the NPL ratio stayed at 2.9 % with coverage of 75 %; cost of risk held at 1.32 % YtD. Capital generation was robust—CET1 FL increased 25 bp in the quarter to 13.34 %, comfortably above the 11.5-12 % target range and the 9.12 % SREP requirement. Total loan book grew 11.2 % YoY (cc), led by Spain (+16 %) and Mexico (+12.6 %). Management raised medium-term guidance: group loans now seen growing above mid-single digits, efficiency ratio <40 %, and CET1 surplus of ~€36 bn available for distribution through 2028. The bank expects around €13 bn excess capital to be distributed in the short term, subject to approvals.
BBVA reported record 1H25 results. Net attributable profit reached €5.45 bn, +31 % YoY (+9 % in current euros), driven by a 20 % rise in gross income to €18 bn. Net interest income climbed 10 % to €12.6 bn and fees grew 18 % to €4 bn, taking core revenues to €16.6 bn (+12 %). Operating costs increased 10 %—well below the 13.4 % inflation rate—improving the efficiency ratio 322 bp to 37.6 % and lifting operating income 26 % to €11.25 bn.
Asset-quality metrics remained solid: cost of risk 1.32 %, NPL ratio 2.9 %, coverage 81 %. The CET1 fully-loaded ratio rose 25 bp to 13.34 %, above the 11.5-12 % target range. 2Q25 standalone profit was €2.75 bn (+18 % YoY). Profitability stayed ahead of European peers with ROTE 20.4 % and ROE 19.5 %.
Regional highlights (1H25): Spain €2.14 bn (+21 %), Mexico €2.58 bn (+6 %), Türkiye €0.41 bn (+17 %), South America €0.42 bn (+33 %). Loans grew 16 % in constant FX and the bank added 5.7 m new customers.
Outlook: For 2025 BBVA guides to ROTE ~20 % and efficiency <40 %. The 2025-28 plan targets cumulative profit of ~€48 bn, average ROTE ~22 %, and efficiency ~35 %. Management projects €49 bn CET1 generation over four years, allocating ~€13 bn to growth and ~€36 bn (70 %) to shareholder distributions via dividends and buybacks.
BBVA 1H25: Net attributable profit €5.45 bn, up 9.1 % YoY (+31 % cFX), powered by 11.6 % growth in NII+fees and tight cost control that pushed the efficiency ratio down to 37.6 %. ROTE reached 20.4 % and ROE 19.5 %. Cost of risk held at 1.32 % and the NPL ratio stayed at 2.9 % with 81 % coverage.
Balance-sheet strength: Loans grew 3.4 % (+8.1 % cFX) to €438 bn; customer funds rose 1.7 % to €651 bn. The CET1 ratio climbed to 13.34 %, sitting well above the 11.5–12 % target band, while total capital stood at 17.7 % and the leverage ratio at 6.9 %. Liquidity remains ample (LCR 140 %, NSFR 126 %).
Regional mix: Spain earned €2.14 bn (+21 %), Mexico €2.58 bn (+6 %), Turkey €0.41 bn (+17 %), South America €0.42 bn (+33 %), Rest of Business €0.30 bn (+31 %); Corporate Center loss narrowed to €-0.41 bn.
Capital actions & M&A: FY-24 cash dividends totalled €0.70 per share and a €993 m buyback is pending. The voluntary offer for Banco Sabadell cleared Spanish competition and ministerial reviews, subject to a three-year autonomy condition, and BBVA will proceed.
Sustainability: New €700 bn 2025-29 sustainable business goal; €63 bn channelled in 1H25 (+48 % YoY), 76 % environmental.
Key event: Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) has filed a Form 6-K announcing that its Board of Directors has approved an issuance of securities that are contingently convertible into newly issued ordinary BBVA shares for an aggregate amount of up to €1.5 billion. The issuance will be carried out without pre-emption rights for existing shareholders.
Terms still pending: The filing states that BBVA will disclose the specific terms and timing when it decides to execute the transaction. No details on pricing, coupon, conversion trigger, or schedule are included in this report.
Regulatory context: The announcement is classified as “Inside Information” under Spanish Securities-Market legislation and is being furnished to the U.S. SEC under Rule 13a-16/15d-16. The document is signed by José María Caballero Cobacho, Global ALM Director, on 25 June 2025.
Immediate implications: • Board authorization enables BBVA to raise capital through contingent convertible instruments up to the stated limit.
• Exclusion of pre-emption rights means existing shareholders will not have an automatic allocation in the potential offering.
• Because conversion would involve issuing new ordinary shares, future dilution is possible if the instruments are triggered, but the impact cannot be assessed until full terms are released.